Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

PharmacoEconomics / Springer

Citation Profile [Updated: 2019-12-04 10:36:47]
5 Years H
11
Impact Factor
0.17
5 Years IF
0.2
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1990 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1991 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1992 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1993 0 0.1 0 0 0 0 0 0 0 0 0 0 0.05
1994 0 0.11 0 0 0 0 0 0 0 0 0 0 0.05
1995 0 0.19 0 0 0 0 0 0 0 0 0 0 0.08
1996 0 0.22 0 0 0 0 0 0 0 0 0 0 0.1
1997 0 0.22 0 0 10 10 6 0 0 0 0 0 0.09
1998 0 0.26 0 0 12 22 1 0 10 10 0 0 0.12
1999 0 0.28 0.18 0 0 22 0 4 22 22 0 0 0.14
2000 0 0.33 0.03 0.05 9 31 0 1 5 12 22 1 0 0 0.15
2001 0 0.36 0 0 3 34 0 5 9 31 0 0 0.15
2002 0 0.39 0.03 0.03 0 34 0 1 6 12 34 1 0 0 0.21
2003 0 0.4 0.03 0 5 39 0 1 7 3 24 0 0 0.2
2004 0 0.45 0.03 0 1 40 1 1 8 5 17 0 0 0.2
2005 0 0.46 0.02 0 7 47 1 1 9 6 18 0 0 0.22
2006 0 0.46 0.02 0.06 62 109 42 2 11 8 16 1 1 50 0 0.21
2007 0.03 0.42 0.02 0.03 38 147 15 3 14 69 2 75 2 0 0 0.18
2008 0.01 0.44 0.01 0.01 22 169 70 1 15 100 1 113 1 1 100 0 0.21
2009 0 0.44 0.02 0.01 28 197 9 3 18 60 130 1 0 0 0.21
2010 0.1 0.43 0.04 0.06 33 230 20 10 28 50 5 157 9 0 0 0.18
2011 0.05 0.46 0.03 0.04 32 262 46 9 37 61 3 183 7 3 33.3 2 0.06 0.21
2012 0.08 0.47 0.07 0.08 87 349 70 25 62 65 5 153 12 5 20 5 0.06 0.19
2013 0.19 0.53 0.13 0.16 96 445 179 56 118 119 23 202 32 21 37.5 11 0.11 0.22
2014 0.16 0.55 0.16 0.14 123 568 173 92 210 183 30 276 38 32 34.8 34 0.28 0.22
2015 0.26 0.56 0.18 0.2 105 673 94 122 332 219 57 371 75 33 27 17 0.16 0.21
2016 0.23 0.58 0.19 0.22 145 818 66 152 484 228 52 443 98 38 25 14 0.1 0.2
2017 0.16 0.6 0.19 0.19 116 934 52 176 660 250 41 556 103 52 29.5 24 0.21 0.22
2018 0.17 0.76 0.18 0.2 127 1061 15 189 849 261 45 585 115 36 19 7 0.06 0.31
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
CIF: Cumulative impact factor
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

115
22008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

56
3Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

23
42014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

22
52012Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Woolacott, Nerys ; Bojke, Laura ; Light, Kate ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270.

Full description at Econpapers || Download paper

22
62014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

22
72014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

14
82015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Meyerhoefer, Chad ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

14
92017Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4.

Full description at Econpapers || Download paper

12
102014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

12
112014Capital’s grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30.

Full description at Econpapers || Download paper

11
122014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

11
132014Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

11
142013Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10.

Full description at Econpapers || Download paper

10
152014Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127.

Full description at Econpapers || Download paper

9
162006Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902.

Full description at Econpapers || Download paper

9
172015Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Nilsson, Fredrik ; Arnberg, Karl . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236.

Full description at Econpapers || Download paper

9
182014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

8
192014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

8
202015Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework. (2015). McCabe, Christopher ; Stafinski, Tania ; Paulden, Mike ; Menon, Devidas . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:255-269.

Full description at Econpapers || Download paper

8
212015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924.

Full description at Econpapers || Download paper

8
222012Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211.

Full description at Econpapers || Download paper

8
23Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

7
242013Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797.

Full description at Econpapers || Download paper

7
252014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

7
262016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1.

Full description at Econpapers || Download paper

7
272012Does the EQ-5D Reflect Lost Earnings?. (2012). van Exel, Job ; Tsuchiya, Aki ; Brouwer, Werner ; Kro, Marieke ; Brazier, John ; Tilling, Carl . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:47-61.

Full description at Econpapers || Download paper

6
282015A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions. (2015). Ijzerman, Maarten ; Broekhuizen, Henk ; Groothuis-Oudshoorn, Catharina ; Til, Janine ; Hummel, J.. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:445-455.

Full description at Econpapers || Download paper

6
292015Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. (2015). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana ; Wetering, Liesbet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:12:p:1289-1300.

Full description at Econpapers || Download paper

6
302006The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25.

Full description at Econpapers || Download paper

6
312015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

6
322016Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z.

Full description at Econpapers || Download paper

6
332011Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Papenburg, Joce ; Krol, Marieke ; Koopmanschap, Marc . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619.

Full description at Econpapers || Download paper

5
342016Biosimilars: How Can Payers Get Long-Term Savings?. (2016). Towse, Adrian ; Berdud, Mikel ; Mestre-Ferrandiz, Jorge. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:6:d:10.1007_s40273-015-0380-x.

Full description at Econpapers || Download paper

5
352014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

5
362006Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf ; Wille, Nora ; Bullinger, Monika ; Erhart, Michael . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220.

Full description at Econpapers || Download paper

5
372008Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616.

Full description at Econpapers || Download paper

5
382013How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119.

Full description at Econpapers || Download paper

5
392014Eliciting Preferences to Inform Patient-Centred Policies: the Case of Psoriasis. (2014). Torbica, Aleksandra ; Fattore, Giovanni ; Ayala, Fabio . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:2:p:209-223.

Full description at Econpapers || Download paper

5
402014The probability of default in Russian banking. (2014). Karminsky, Alexander ; Kostrov, Alexander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:81-98.

Full description at Econpapers || Download paper

5
412016Pharmaceutical Price Schemes in Europe: Time for a ‘Continental’ One?. (2016). Curto, Alessandro ; Freemantle, Nick ; Garattini, Livio. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0377-5.

Full description at Econpapers || Download paper

5
422014Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room. (2014). Pekarsky, Brita ; Eckermann, Simon. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:319-325.

Full description at Econpapers || Download paper

5
432016Complex Valuation: Applying Ideas from the Complex Intervention Framework to Valuation of a New Measure for End-of-Life Care. (2016). Huynh, Elisabeth ; Kinghorn, Philip ; Flynn, Terry ; Coast, Joanna. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0365-9.

Full description at Econpapers || Download paper

5
442012Common Drug Review Recommendations. (2012). Rocchi, Angela ; Goeree, Ron ; Hopkins, Robert ; Miller, Elizabeth. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:229-246.

Full description at Econpapers || Download paper

5
452010International Comparison of Comparative Effectiveness Research in Five Jurisdictions. (2010). Levy, Adrian ; Johnston, Karissa ; Mitton, Craig ; Harrigan, Brian ; Briggs, Andrew. In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:10:p:813-830.

Full description at Econpapers || Download paper

5
462012Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis. (2012). Soares, Marta ; Luisa Canto e Castro, . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:12:p:1101-1117.

Full description at Econpapers || Download paper

5
472010An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions. (2010). Devlin, Nancy ; ONeill, Phill . In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:11:p:987-993.

Full description at Econpapers || Download paper

5
482014Self-employment against employment or unemployment: Markov transitions across the business cycle. (2014). Constant, Amelie ; Zimmermann, Klaus. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:51-87.

Full description at Econpapers || Download paper

5
492006The Value of Thinly Spread QALYs. (2006). Mortimer, Duncan. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:845-853.

Full description at Econpapers || Download paper

4
502014A Comparative Analysis of Two Contrasting European Approaches for Rewarding the Value Added by Drugs for Cancer: England Versus France. (2014). Jones, Elizabeth ; Drummond, Michael ; Haig, Jennifer ; Cawston, Helene ; Saba, Grece ; Pouvourville, Gerard . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:5:p:509-520.

Full description at Econpapers || Download paper

4
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

51
22008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

22
32014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

13
42017Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4.

Full description at Econpapers || Download paper

12
52014Capital’s grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30.

Full description at Econpapers || Download paper

11
62015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Meyerhoefer, Chad ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

9
72014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

8
82016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1.

Full description at Econpapers || Download paper

7
92014Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127.

Full description at Econpapers || Download paper

7
102015Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework. (2015). McCabe, Christopher ; Stafinski, Tania ; Paulden, Mike ; Menon, Devidas . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:255-269.

Full description at Econpapers || Download paper

7
112014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

7
122011Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

6
132016Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z.

Full description at Econpapers || Download paper

6
142015Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. (2015). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana ; Wetering, Liesbet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:12:p:1289-1300.

Full description at Econpapers || Download paper

6
152015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

6
162015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924.

Full description at Econpapers || Download paper

6
172015Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Nilsson, Fredrik ; Arnberg, Karl . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236.

Full description at Econpapers || Download paper

6
182014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

6
192013Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10.

Full description at Econpapers || Download paper

5
202014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

5
212014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

5
222016Complex Valuation: Applying Ideas from the Complex Intervention Framework to Valuation of a New Measure for End-of-Life Care. (2016). Huynh, Elisabeth ; Kinghorn, Philip ; Flynn, Terry ; Coast, Joanna. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0365-9.

Full description at Econpapers || Download paper

5
232016Pharmaceutical Price Schemes in Europe: Time for a ‘Continental’ One?. (2016). Curto, Alessandro ; Freemantle, Nick ; Garattini, Livio. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0377-5.

Full description at Econpapers || Download paper

4
242014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

4
252016Biosimilars: How Can Payers Get Long-Term Savings?. (2016). Towse, Adrian ; Berdud, Mikel ; Mestre-Ferrandiz, Jorge. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:6:d:10.1007_s40273-015-0380-x.

Full description at Econpapers || Download paper

4
262017The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Haycox, Alan ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4.

Full description atA Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. (2017). Brazier, John ; Chevrou-Severac, Helene ; Rowen, Donna ; Ara, Roberta. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0545-x.

Full description at Econpapers || Download paper

4
282013Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797.

Full description at Econpapers || Download paper

4
292017The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; Oliva-Moreno, Juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y.

Full description at Econpapers || Download paper

4
302014The probability of default in Russian banking. (2014). Karminsky, Alexander ; Kostrov, Alexander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:81-98.

Full description at Econpapers || Download paper

3
312018Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Edney, Laura Catherine ; Karnon, Jonathan ; Cheng, Terence Chai ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

Full description at Econpapers || Download paper

3
322014A Comparative Analysis of Two Contrasting European Approaches for Rewarding the Value Added by Drugs for Cancer: England Versus France. (2014). Jones, Elizabeth ; Drummond, Michael ; Haig, Jennifer ; Cawston, Helene ; Saba, Grece ; Pouvourville, Gerard . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:5:p:509-520.

Full description at Econpapers || Download paper

3
332013Decision-Makers’ Preferences for Approving New Medicines in Wales: A Discrete-Choice Experiment with Assessment of External Validity. (2013). Hughes, Dyfrig ; Linley, Warren . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:4:p:345-355.

Full description at Econpapers || Download paper

3
342011Sample Size and Power for Cost-Effectiveness Analysis (Part 1). (2011). Glick, Henry . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:3:p:189-198.

Full description at Econpapers || Download paper

3
352019Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Soekhai, Vikas ; Vass, Caroline M ; Ellis, Alan R ; Bekker-Grob, Esther W. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2.

Full description at Econpapers || Download paper

3
362017The Use of Mapping to Estimate Health State Utility Values. (2017). Ara, Roberta ; Mukuria, Clara ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0548-7.

Full description at Econpapers || Download paper

3
372016Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9.

Full description at Econpapers || Download paper

3
382016Assessing the Value of New Treatments for Hepatitis C: Are International Decision Makers Getting this Right?. (2016). Faria, Rita ; Griffin, Susan ; Woods, Beth . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0369-5.

Full description at Econpapers || Download paper

3
392014Eliciting Preferences to Inform Patient-Centred Policies: the Case of Psoriasis. (2014). Torbica, Aleksandra ; Fattore, Giovanni ; Ayala, Fabio . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:2:p:209-223.

Full description at Econpapers || Download paper

3
402013Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

3
412014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

3
422016A Model-Based Economic Evaluation of Biologic and Non-Biologic Options for the Treatment of Adults with Moderately-to-Severely Active Ulcerative Colitis after the Failure of Conventional Therapy. (2016). Basarir, Hasan ; James, Marrissa Martyn-St ; Harvey, Rebecca ; Archer, Rachel ; Ren, Shijie ; Tappenden, Paul ; Stevens, John ; Lobo, Alan ; Hoque, Sami . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0409-9.

Full description at Econpapers || Download Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Woolacott, Nerys ; Bojke, Laura ; Light, Kate ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270.

Full description at Econpapers || Download paper

3
442014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

3
452018Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Janssen, Mathieu F ; Luo, Nan ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8.

Full description at Econpapers || Download paper

3
462015Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135.

Full description at Econpapers || Download paper

3
472015A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028.

Full description at Econpapers || Download paper

3
482017Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics. (2017). Morrell, Liz ; Barker, Richard ; Rees, Sian ; Wordsworth, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0511-7.

Full description at Econpapers || Download paper

3
492017International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Rowen, Donna ; Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y.

Full description at Econpapers || Download paper

3
502018Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets. (2018). Shah, Koonal ; Feng, Yan ; Devlin, Nancy ; Hout, Ben ; Herdman, Michael ; Janssen, Mathieu F ; Mulhern, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0628-3.

Full description at Econpapers || Download paper

3
Citing documents used to compute impact factor: 45
YearTitle
2018Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates. (2018). Espin, Jaime ; Jommi, Claudio ; Parnaby, Adam ; Flostrand, Steven ; Hutchings, Adam ; Borget, Isabelle ; Mestre-Ferrandiz, Jorge ; Anderson, Pippa ; Godman, Brian ; Schlander, Michael. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:6:d:10.1007_s40258-018-0419-1.

Full description at Econpapers || Download paper

2018Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching. (2018). Husereau, Don ; Selya-Hammer, Carl ; Feagan, Brian. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:3:d:10.1007_s40258-018-0371-0.

Full description at Econpapers || Download paper

2018The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challe. (2018). Ghabri, Salah ; Mauskopf, Josephine . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:2:d:10.1007_s10198-017-0933-3.

Full description at Econpapers || Download paper

2018Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment. (2018). Shah, Koonal ; Feng, Yan ; Cole, Amanda ; Devlin, Nancy ; Mulhern, Brendan. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:4:d:10.1007_s10198-017-0905-7.

Full description at Econpapers || Download paper

2018Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets. (2018). Shah, Koonal ; Feng, Yan ; Devlin, Nancy ; Hout, Ben ; Herdman, Michael ; Janssen, Mathieu F ; Mulhern, Brendan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0628-3.

Full description at Econpapers || Download paper

2018Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Janssen, Mathieu F ; Luo, Nan ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8.

Full description at Econpapers || Download paper

2018German Value Set for the EQ-5D-5L. (2018). Ludwig, Kristina ; Greiner, Wolfgang ; von der Schulenburg, J-Matthias Graf ; J-Matthias Graf von der Schulenburg, . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8.

Full description at Econpapers || Download paper

2018Experience-Based Values: A Framework for Classifying Different Types of Experience in Health Valuation Research. (2018). Shah, Koonal ; Cubi-Molla, Patricia ; Burstrom, Kristina . In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:3:d:10.1007_s40271-017-0292-2.

Full description at Econpapers || Download paper

2018How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts. (2018). Wieser, Simon ; Schwenkglenks, Matthias ; Telser, Harry ; Huber, Carola A ; Pletscher, Mark ; Riguzzi, Marco. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:8:d:10.1007_s10198-018-0963-5.

Full description at Econpapers || Download paper

2018Pharmaceutical pricing conundrum: time to get rid of it?. (2018). Garattini, Livio ; Padula, Anna. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:8:d:10.1007_s10198-018-0995-x.

Full description at Econpapers || Download paper

2018Incorporating equity in economic evaluations: a multi-attribute equity state approach. (2018). Round, Jeff ; Paulden, Mike. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:4:d:10.1007_s10198-017-0897-3.

Full description at Econpapers || Download paper

2018A Systematic Review Comparing the Acceptability, Validity and Concordance of Discrete Choice Experiments and Best–Worst Scaling for Eliciting Preferences in Healthcare. (2018). Whitty, Jennifer A ; Oliveira, Ana Sofia. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:3:d:10.1007_s40271-017-0288-y.

Full description at Econpapers || Download paper

2018Raise the Bar, Not the Threshold Value: Meeting Patient Preferences for Palliative and End-of-Life Care. (2018). McCaffrey, Nikki ; Eckermann, Simon. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0039-y.

Full description at Econpapers || Download paper

2018Spillover Effects of Maternal Chronic Disease on Children’s Quality of Life and Behaviors Among Low-Income Families. (2018). , Vivian ; Ip, Patrick ; Carlos , . In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:6:d:10.1007_s40271-018-0314-8.

Full description at Econpapers || Download paper

2018Uncontrolled diabetes and health care utilisation: panel data evidence from Spain. (2018). Zucchelli, Eugenio ; Sicras-Mainar, Antoni ; Gil, Joan. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:6:d:10.1007_s10198-017-0920-8.

Full description at Econpapers || Download paper

2018Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. (2018). Angelis, Aris ; Kanavos, Panos ; Lange, Ansgar . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:1:d:10.1007_s10198-017-0871-0.

Full description at Econpapers || Download paper

2018Access to orphan drugs – comparison across Balkan countries. (2018). Pejcic, Ana V ; Stefanov, Rumen ; Jakovljevic, Mihajlo Michael ; Iskrov, Georgi . In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:6:p:583-589.

Full description at Econpapers || Download paper

2018A multi-criteria decision approach for ranking unmet needs in healthcare. (2018). Cleemput, Irina ; Westhovens, Rene ; Kohn, Laurence ; Devriese, Stephan . In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:8:p:878-884.

Full description at Econpapers || Download paper

2018Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom. (2018). Wilson, Michele R ; Kerrigan, Matthew C ; Smyth, Michael ; Selby, Ross ; Chevrou-Severac, Helene ; Bergman, Annika. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:2:d:10.1007_s10198-017-0879-5.

Full description at Econpapers || Download paper

2018Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review. (2018). Lancsar, Emily ; Gu, Yuanyuan ; Zavarsek, Silva ; Ghijben, Peter . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:3:d:10.1007_s40273-017-0586-1.

Full description at Econpapers || Download paper

2018Contributions of multiple climate hazards and overgrazing to the 2009/2010 winter disaster in Mongolia. (2018). Nandintsetseg, Banzragch ; Erdenetsetseg, Baasandai ; Shinoda, Masato. In: Natural Hazards: Journal of the International Society for the Prevention and Mitigation of Natural Hazards. RePEc:spr:nathaz:v:92:y:2018:i:1:d:10.1007_s11069-017-2954-8.

Full description at Econpapers || Download paper

2018Competition in pharmaceuticals: more product- than price-oriented?. (2018). Garattini, Livio ; Padula, Anna. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:1:d:10.1007_s10198-017-0932-4.

Full description at Econpapers || Download paper

2018Patient empowerment in Europe: is no further research needed?. (2018). Garattini, Livio ; Padula, Anna. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:5:d:10.1007_s10198-018-0965-3.

Full description at Econpapers || Download paper

2018Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People’s Quality of Life Brief Questionnaire (OPQoL-Brief) Scores. (2018). Kaambwa, Billingsley ; Ratcliffe, Julie. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:1:d:10.1007_s40271-017-0259-3.

Full description at Econpapers || Download paper

2018Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway. (2018). Wisloff, Torbjorn ; Klovstad, Hilde ; Lovlie, Astrid Louise ; Meijerink, Hinta ; Amundsen, Ellen J ; Dalgard, Olav ; White, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-017-0604-3.

Full description at Econpapers || Download paper

2018Uptake of and Expenditure on Direct-Acting Antiviral Agents for Hepatitis C Treatment in Australia. (2018). de Graaff, Barbara ; Palmer, Andrew ; Clarke, Philip ; Yee, Kwang Chien . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:4:d:10.1007_s40258-018-0392-8.

Full description at Econpapers || Download paper

2018Are PCSK9 Inhibitors Cost Effective?. (2018). Korman, Max J ; Wisloff, Torbjorn ; Kristiansen, Ivar Sonbo ; Retterstol, Kjetil. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:9:d:10.1007_s40273-018-0671-0.

Full description at Econpapers || Download paper

2018Mekong River Delta farm-household willingness to pay for salinity intrusion risk reduction. (2018). Khong, Tien Dung ; Thennakoon, Jayanthi ; Loch, Adam ; Young, Michael D. In: Agricultural Water Management. RePEc:eee:agiwat:v:200:y:2018:i:c:p:80-89.

Full description at Econpapers || Download paper

2018Farmers preferences for site-specific extension services: Evidence from a choice experiment in Nigeria. (2018). Chamberlin, Jordan ; Maertens, Miet ; Craufurd, Peter ; Kamara, Alpha ; Vranken, Liesbet ; Vanlauwe, Bernard ; Oyinbo, Oyakhilomen. In: Working Papers. RePEc:ags:kucawp:276175.

Full description at Econpapers || Download paper

2018Maize Farmers Preferences for ICT-based extension services: Evidence from a Choice Experiment in Nigeria. (2018). Chamberlin, Jordan ; Kamara, A ; Craufurd, P ; Vanlauwe, B ; Maertens, M ; Oyinbo, O. In: 2018 Conference, July 28-August 2, 2018, Vancouver, British Columbia. RePEc:ags:iaae18:277328.

Full description at Econpapers || Download paper

2018Adoption of improved quinoa varieties among smallholder farmers in the Peruvian Andes. (2018). Maertens, Miet ; van den Broeck, Goedele ; Gamboa, Cindybell. In: Working Papers. RePEc:ags:kucawp:277984.

Full description at Econpapers || Download paper

2018Smallholders’ Preferences for Improved Quinoa Varieties in the Peruvian Andes. (2018). Gamboa, Cindybell ; Maertens, Miet ; van den Broeck, Goedele. In: Sustainability. RePEc:gam:jsusta:v:10:y:2018:i:10:p:3735-:d:176246.

Full description at Econpapers || Download paper

2018Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience. (2018). , William ; Edwards, Guy J ; Levy, Pierre ; Staufer, Alexandra. In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:5:p:528-532.

Full description at Econpapers || Download paper

2018Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review. (2018). Dukhanin, Vadim ; Merritt, Maria W ; Taylor, Holly A ; Dowdy, David W ; Zwerling, Alice ; Searle, Alexandra. In: Social Science & Medicine. RePEc:eee:socmed:v:198:y:2018:i:c:p:27-35.

Full description at Econpapers || Download paper

2018An Extended Cost-Effectiveness Analysis of Tobacco Price Increases in the Kyrgyz Republic. (2018). Group, World Bank. In: World Bank Other Operational Studies. RePEc:wbk:wboper:29819.

Full description at Econpapers || Download paper

2018Using path analysis to investigate the relationships between standardized instruments that measure health-related quality of life, capability wellbeing and subjective wellbeing: An application in the . (2018). Engel, Lidia ; David, ; Noonan, Vanessa K ; Bryan, Stirling. In: Social Science & Medicine. RePEc:eee:socmed:v:213:y:2018:i:c:p:154-164.

Full description at Econpapers || Download paper

2018Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies. (2018). Makady, Amr ; Goettsch, Wim ; Klungel, Olaf ; Hillege, Hans ; Boer, Anthonius ; Dandon, Anne ; Moseley, Owen ; Jonsson, Pall ; Veelen, Ard. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:3:d:10.1007_s40273-017-0596-z.

Full description at Econpapers || Download paper

2018Valuing health at the end of life: A review of stated preference studies in the social sciences literature. (2018). Tsuchiya, Aki ; Shah, Koonal ; Wailoo, Allan J. In: Social Science & Medicine. RePEc:eee:socmed:v:204:y:2018:i:c:p:39-50.

Full description at Econpapers || Download paper

2018The health care costs of childhood obesity in Australia: An instrumental variables approach. (2018). Jones, Andrew ; Hughes, Robert ; Black, Nicole. In: Economics & Human Biology. RePEc:eee:ehbiol:v:31:y:2018:i:c:p:1-13.

Full description at Econpapers || Download paper

2018Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study. (2018). Husbands, Samantha ; Coast, Joanna ; Barton, Pelham ; Jowett, Susan . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0705-7.

Full description at Econpapers || Download paper

2018Using Evidence from Randomised Controlled Trials in Economic Models: What Information is Relevant and is There a Minimum Amount of Sample Data Required to Make Decisions?. (2018). Stevens, John W. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:10:d:10.1007_s40273-018-0681-y.

Full description at Econpapers || Download paper

2018Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong. (2018). , Eliza ; Rivero-Arias, Oliver ; Ramos-Goi, Juan Manuel. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:2:d:10.1007_s40271-017-0278-0.

Full description at Econpapers || Download paper

2018Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index–9 Dimension (CHU-9D) Score for Economic Evaluation in Children. (2018). Lambe, Tosin ; Barsoum, Emma N ; Brettell, Elizabeth A ; Cummins, Carole ; Woolley, Rebecca L ; Ives, Natalie J ; Frew, Emma. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:4:d:10.1007_s40273-017-0600-7.

Full description at Econpapers || Download paper

2018Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15. (2018). Petersen, Karin Dam ; Ratcliffe, Julie ; Brazier, John ; Stevens, Katherine ; Mpundu-Kaambwa, Christine ; Chen, Gang. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:1:d:10.1007_s40271-017-0265-5.

Full description at Econpapers || Download paper

2018A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values. (2018). Petrou, Stavros ; Madan, Jason ; Kwon, Joseph. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:9:d:10.1007_s40273-018-0670-1.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2018
YearCiting document
2018Estimating the marginal productivity of the English National Health Service from 2003/04 to 2012/13. (2018). Claxton, Karl ; Martin, Stephen ; Lomas, James. In: Working Papers. RePEc:chy:respap:158cherp.

Full description at Econpapers || Download paper

2018Intended and unintended impacts of price changes for drugs and medical services: Evidence from China. (2018). Fu, Hongqiao ; Yip, Winnie ; Li, Ling. In: Social Science & Medicine. RePEc:eee:socmed:v:211:y:2018:i:c:p:114-122.

Full description at Econpapers || Download paper

2018Model Structuring for Economic Evaluations of New Health Technologies. (2018). Ali, Hossein Haji ; Karnon, Jonathan ; Bojke, Laura. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:11:d:10.1007_s40273-018-0693-7.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Mestre-Ferrandiz, Jorge ; Hidalgo-Vega, alvaro ; Alcala, Bleric ; Zozaya, Neboa . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4.

Full description at Econpapers || Download paper

20183L, 5L, What the L? A NICE Conundrum. (2018). Devlin, Nancy ; Stolk, Elly ; Pickard, Simon A ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0622-9.

Full description at Econpapers || Download paper

2018Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values. (2018). Selivanova, Anna ; Buskens, Erik . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0647-0.

Full description at Econpapers || Download paper

Recent citations received in 2017
YearCiting document
2017Valuing Informal Care in Ireland: Beyond the Traditional Production Boundary. (2017). Hanly, Paul ; Sheerin, Corina. In: The Economic and Social Review. RePEc:eso:journl:v:48:y:2017:i:3:p:337-364.

Full description at Econpapers || Download paper

2017Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges. (2017). Lamsal, Ramesh ; Zwicker, Jennifer D. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:6:d:10.1007_s40258-017-0343-9.

Full description at Econpapers || Download paper

2017The Ball is in Your Court: Agenda for Research to Advance the Science of Patient Preferences in the Regulatory Review of Medical Devices in the United States. (2017). Levitan, Bennett ; Christopher, Stephanie ; Jaffe, Ross ; Damiano, Marina G ; Hauber, Brett A. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:10:y:2017:i:5:d:10.1007_s40271-017-0272-6.

Full description at Econpapers || Download paper

2017Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment. (2017). Salleh, Syed ; Dixon, Simon ; Hughes, Ruby ; Brennan, Alan ; Thokala, Praveen. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0533-1.

Full description at Econpapers || Download paper

2017Response to ‘Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”’. (2017). Bermejo, Inigo ; Youn, Ji-Hee ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0574-5.

Full description at Econpapers || Download paper

2017Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”. (2017). McManus, Emma ; Sach, Tracey. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0576-3.

Full description at Econpapers || Download paper

2017The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Haycox, Alan ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4.

Full description atHeath State Utility Values for Cost-Effectiveness Models. (2017). Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0537-x.

Full description at Econpapers || Download paper

2017The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment. (2017). Rowen, Donna ; Zouraq, Ismail Azzabi ; Ara, Roberta ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0546-9.

Full description at Econpapers || Download paper

2017The Identification, Review and Synthesis of Health State Utility Values from the Literature. (2017). Ara, Roberta ; Paisley, Suzy ; Peasgood, Tessa ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0547-8.

Full description at Econpapers || Download paper

2017The Use of Mapping to Estimate Health State Utility Values. (2017). Ara, Roberta ; Mukuria, Clara ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0548-7.

Full description at Econpapers || Download paper

2017Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies. (2017). Ara, Roberta ; Young, Tracey ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0549-6.

Full description at Econpapers || Download paper

2017The Use of Health State Utility Values in Decision Models. (2017). Ara, Roberta ; Zouraq, Ismail Azzabi ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0550-0.

Full description at Econpapers || Download paper

2017Making Implicit Assumptions Explicit in the Costing of Informal Care: The Case of Head and Neck Cancer in Ireland. (2017). Hanly, Paul ; Sharp, Linda ; Osullivan, Eleanor ; Balfe, Myles ; Maguire, Rebecca. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:5:d:10.1007_s40273-017-0490-8.

Full description at Econpapers || Download paper

2017Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NI. (2017). , Bram ; Joore, Manuela A ; Kleijnen, Jos ; Severens, Johan L ; Armstrong, Nigel ; Duffy, Steven ; Deshpande, Sohan ; Asselt, Thea ; Tomini, Florian ; Riemsma, Rob. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:6:d:10.1007_s40273-017-0507-3.

Full description at Econpapers || Download An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments. (2017). Engel, Lidia ; David, ; Lear, Scott A ; Bryan, Stirling ; Mortimer, Duncan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0491-7.

Full description at Econpapers || Download paper

2017Ahead of Our Time: Collaboration in Modeling Then and Now. (2017). , Renee ; Ekins, Sean . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0532-2.

Full description at Econpapers || Download paper

Recent citations received in 2016
YearCiting document
2016Fairer decisions, better health for all: Health equity and cost-effectiveness analysis. (2016). Asaria, Miqdad ; Mirelman, Andrew ; Cookson, Richard ; Griffin, Susan ; Dawkins, Bryony . In: Working Papers. RePEc:chy:respap:135cherp.

Full description at Econpapers || Download paper

2016Expanding professional pharmacy services in European community setting: Is it cost-effective? A systematic review for health policy considerations. (2016). Bugnon, Olivier ; Perraudin, Clemence ; Pelletier-Fleury, Nathalie . In: Health Policy. RePEc:eee:hepoli:v:120:y:2016:i:12:p:1350-1362.

Full description at Econpapers || Download paper

2016Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers?. (2016). Gandjour, Afschin. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:14:y:2016:i:5:d:10.1007_s40258-016-0247-0.

Full description at Econpapers || Download paper

2016Reimbursable drug classes and ceilings in Italy: why not only one?. (2016). Padula, Anna ; Curto, Alessandro ; Garattini, Livio. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:17:y:2016:i:8:d:10.1007_s10198-016-0808-z.

Full description at Econpapers || Download paper

2016Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic Evidence. (2016). Faria, Rita ; Llewellyn, Alexis ; Woods, Beth ; Griffin, Susan ; Woolacott, Nerys ; Lomas, James ; Simmonds, Mark . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0418-8.

Full description at Econpapers || Download paper

2016Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience. (2016). Bocquet, Franois ; Paubel, Pascal ; Cordonnier, Anne-Laure ; Fusier, Isabelle ; Loubiere, Anais . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0428-6.

Full description at Econpapers || Download paper

2016Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis. (2016). Onukwugha, Eberechukwu . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:2:d:10.1007_s40273-015-0378-4.

Full description at Econpapers || Download paper

2016Big Data and Its Role in Health Economics and Outcomes Research: A Collection of Perspectives on Data Sources, Measurement, and Analysis. (2016). Onukwugha, Eberechukwu . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:2:p:91-93.

Full description at Econpapers || Download paper

2016Why Cancer?. (2016). Haycox, Alan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0413-0.

Full description at Econpapers || Download paper

2016Model Validation: Has it’s Time Come?. (2016). Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0415-y.

Full description at Econpapers || Download paper

Recent citations received in 2015
YearCiting document
2015Neural Network Estimators of Binary Choice Processes: Estimation, Marginal Effects and WTP. (2015). Bergtold, Jason ; Ramsey, Steven M. In: 2015 AAEA & WAEA Joint Annual Meeting, July 26-28, San Francisco, California. RePEc:ags:aaea15:205649.

Full description at Econpapers || Download paper

2015Reporting error in weight and its implications for bias in economic models. (2015). Maclean, Johanna ; Cawley, John ; Hammer, Mette ; Wintfeld, Neil . In: Economics & Human Biology. RePEc:eee:ehbiol:v:19:y:2015:i:c:p:27-44.

Full description at Econpapers || Download paper

2015An economy of scales: A selective review of obesitys economic causes, consequences, and solutions. (2015). Cawley, John. In: Journal of Health Economics. RePEc:eee:jhecon:v:43:y:2015:i:c:p:244-268.

Full description at Econpapers || Download paper

2015Assessing sufficient capability: A new approach to economic evaluation. (2015). Mitchell, Paul Mark ; Coast, Joanna ; Barton, Pelham M ; Roberts, Tracy E. In: Social Science & Medicine. RePEc:eee:socmed:v:139:y:2015:i:c:p:71-79.

Full description at Econpapers || Download paper

2015Unpaid work in health economic evaluations. (2015). Brouwer, Werner ; Krol, Marieke . In: Social Science & Medicine. RePEc:eee:socmed:v:144:y:2015:i:c:p:127-137.

Full description at Econpapers || Download paper

2015Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:13:y:2015:i:5:p:437-443.

Full description at Econpapers || Download paper

2015Is personalized medicine a panacea for health management? Some thoughts on its desirability. (2015). Rodriguez-Ibeas, Roberto ; Juarez-Castello, Carmelo ; Antoanzas, Fernando. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:16:y:2015:i:5:p:455-457.

Full description at Econpapers || Download paper

2015Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement. (2015). Gray, Alastair ; Petrou, Stavros ; Froud, Robert ; Oppe, Mark ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:985-991.

Full description at Econpapers || Download paper

2015For a Step Change to Curb the Obesity Epidemic. (2015). Cremieux, Pierre-Yves ; Frois, Christian . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:613-617.

Full description at Econpapers || Download paper

2015The Economic Burden of Obesity by Glycemic Stage in the United States. (2015). Li, Qian ; Graf, Thomas ; Hammer, Mette ; Huang, Joanna ; Blume, Steven . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:735-748.

Full description at Econpapers || Download paper

2015Development and Use of Disease-Specific (Reference) Models for Economic Evaluations of Health Technologies: An Overview of Key Issues and Potential Solutions. (2015). Frederix, Gerardus ; Ward, Robyn ; Dasbach, Erik ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:777-781.

Full description at Econpapers || Download paper